Literature DB >> 17073910

Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of bevacizumab (Avastin).

Timothy W Isaacs, Chris Barry.   

Abstract

A 70-year-old man with asymptomatic proliferative diabetic retinopathy received a single intravitreal injection of bevacizumab (Avastin). One month following treatment there was complete resolution of new vessels.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17073910     DOI： 10.1111/j.1442-9071.2006.01378.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN： 1442-6404            Impact factor:   4.207


  8 in total

1.  Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.

Authors:  Amod Gupta; Reema Bansal; Vishali Gupta; Mangat R Dogra
Journal:  Int Ophthalmol       Date:  2012-03-27       Impact factor: 2.031

2.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

3.  Acute bacterial endophthalmitis after intravitreal bevacizumab injection: Case report and literature review.

Authors:  Saba Al Rashaed; Abdulaziz Rushood
Journal:  Saudi J Ophthalmol       Date:  2012-04-28

4.  Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture.

Authors:  J Fernando Arevalo; Juan G Sanchez; Andres F Lasave; Lihteh Wu; Mauricio Maia; Sergio Bonafonte; Miguel Brito; Arturo A Alezzandrini; Natalia Restrepo; Maria H Berrocal; Mario Saravia; Michel Eid Farah; Jans Fromow-Guerra; Virgilio Morales-Canton
Journal:  J Ophthalmol       Date:  2011-03-30       Impact factor: 1.909

5.  Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.

Authors:  Zhale Rajavi; Sare Safi; Mohammad Ali Javadi; Mohsen Azarmina; Siamak Moradian; Morteza Entezari; Ramin Nourinia; Hamid Ahmadieh; Armin Shirvani; Saeid Shahraz; Alireza Ramezani; Mohammad Hossein Dehghan; Mohsen Shahsavari; Masoud Soheilian; Homayoun Nikkhah; Hossein Ziaei; Hasan Behboudi; Fereydoun Farrahi; Khalil Ghasemi Falavarjani; Mohammad Mehdi Parvaresh; Hamid Fesharaki; Majid Abrishami; Nasser Shoeibi; Mansour Rahimi; Alireza Javadzadeh; Reza Karkhaneh; Mohammad Riazi-Esfahani; Masoud Reza Manaviat; Alireza Maleki; Bahareh Kheiri; Faegheh Golbafian
Journal:  J Ophthalmic Vis Res       Date:  2016 Oct-Dec

6.  The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects.

Authors:  Cengiz Alagöz; Yusuf Yıldırım; Murat Kocamaz; Ökkeş Baz; Uğur Çiçek; Burcu Çelik; Halil İbrahim Demirkale; Ahmet Taylan Yazıcı; Muhittin Taşkapılı
Journal:  Turk J Ophthalmol       Date:  2016-10-17

Review 7.  The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice.

Authors:  Nazimul Hussain; Yashoda Ghanekar; Inderjeet Kaur
Journal:  Indian J Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 1.848

8.  Intravitreal Ranibizumab Injection as an Adjuvant in the Treatment of Neovascular Glaucoma Accompanied by Vitreous Hemorrhage after Diabetic Vitrectomy.

Authors:  Xi Shen; Yanwei Chen; Yanuo Wang; Lu Yang; Yisheng Zhong
Journal:  J Ophthalmol       Date:  2016-05-16       Impact factor: 1.909
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.